Last reviewed · How we verify
NCT07501390
Effectiveness Of Early Bed Mobility Exercises And Ambulation In Post Operative Cesarean Section Pain Reduction
NA trial testing Early Bed Mobility Exercises and Ambulation in Cesarean Section in 56 participants. Completed in 22 March 2026.
11 December 2025
Quick facts
| Lead sponsor | Lady Reading Hospital, Pakistan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 25 March 2025 |
| Primary completion | 11 December 2025 |
| Estimated completion | 22 March 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Early Bed Mobility Exercises and Ambulation
- Routine Nursing Care
Conditions studied
- Cesarean Section — all drugs for Cesarean Section →
- Exercise Therapy — all drugs for Exercise Therapy →
- Early Ambulation — all drugs for Early Ambulation →
Sponsor
Lady Reading Hospital, Pakistan
Who can join
Adults 18 to 40, female only, with Cesarean Section or Exercise Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effectiveness of early bed mobility exercises and ambulation in reducing post-operative pain among women who undergo elective cesarean section. A randomized controlled trial will be conducted with 56 participants divided into intervention and control groups. The intervention group will receive physiotherapy exercises such as pelvic rolling, breathing exercises, and ambulation, while the control group will receive routine nursing care. Pain intensity will be assessed using the Visual Analog Scale (VAS) and Numerical Pain Rating Scale (NPRS). The study is expected to show that early mobilization reduces pain, improves recovery, and enhances overall well-being.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07501390
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cesarean Section
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting
Other Lady Reading Hospital, Pakistan trials
Trials by the same sponsor.
- NCT07280975 — Comparing Polyglactin vs Polypropylene Sutures for Rectus Sheath Closure · NA · not yet recruiting
- NCT07183930 — Tubeless vs Tube PCNL in Pediatric Nephrolithiasis: A Randomized Controlled Trial. · NA · completed
- NCT07021300 — Early Versus Interval Laparoscopic Cholecystectomy for Acute Cholecystitis · NA · completed
- NCT06021990 — Clopidogrel for the Prevention of Exacerbations in Severe COPD · Phase 3 · unknown
- NCT05255848 — Nebulised Heparin in Patients With COVID-19 Pneumonia · Phase 2, PHASE3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07501390 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lady Reading Hospital, Pakistan
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07501390.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing